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Duhring presented his classic deseription of
dermatitis herpetiformis in 1884.' His paper was
comprehensive and included all the varieties then
known: the erythematous, vesicular, bullous,
pustular and mixed types. Prior to this Jonathan
Green' in 1838 had emphasized the intense pm-
ritus as the most remarkable and distressing
symptom. Tiibury Fox' in 1880 had delineated
the chronicity, tendency to recurrence, grouping
of vesicles and the usual good health of the pa-
tient with this condition. Bunel4 described the
condition we call herpes gestationis in 1811, the
name given to it by Bu&ley' in 1873.
The case reports and papers increased in num-
ber and varied to such a degree that we soon
come upon the following statement by White6 in
1898: "This case and others which would present
themselves in the next 20 years would show that
we could not accept a narrow definition of derma-
titis herpetiformis, or else we must invent a half
dozen more names". In the same year Jamieson
wrote the following: "are we to make it (derma-
titis herpetiformis) so wide as to include all those
types alluded to, or are we to narrow the circle
and exclude some of the ailments mentioned?"
Hence we find ourselves in 1958, 60 years later,
asking the same question. Is dermatitis herpeti-
formis to be considered a clinical entity or is it
merely a symptom complex?
The diagnosis of dermatitis herpetiformis from
its beginnings to the present time has remained a
clinical impression. There are no specific confirm-
atory laboratory tests; even the biopsy is regarded
by most dermopathologists as non-specific.8
What is the clinical picture of dermatitis her-
petiformis? In Table I we have outlined the prin-
ciples suggested by Duhring in his paper. It
emphasizes his broad concept of the disease. On
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the other hand others, Boeck9 in particular, main-
tained that with the exception of a few general-
ized cases which are difficult there is not a der-
matitis so especially localized and characteristic.
Our presentation is based upon an experience
with a group of cases observed in a twenty year
period from 1937 to 1957. We used as criteria for
diagnosis the occurrence of the condition in
healthy adults, the history of chronicity and rc
currence, the constancy of the physical findings:
symmetry, grouping of vesicles and papules, pig-
mentary changes, scarring, the absence of mucous
membrane lesions; and finally in our series the
clear cut and ready response to sulfapyridine.
This experience is recorded in detail in Table II.
There were 22 cases of which four were females.
The ages of the patients ranged from 17 to 67
years. The duration of the disease in these pa-
tients at the onset of our period of observation
and treatment ranged from 2 months to 17 years.
The duration of observation and treatment varied
from a minimum of one year to the longest period
of 14 years. Of these, 6 were for a minimum of ten
years. These figures are particularly singled out
to emphasize that despite the tremendous varia-
tion in time, the behavior pattern and response
to treatment were the same. We particularly call
attention to the relatively small dosage of sulfa-
pyridine required for purposes of suppression and
the even smaller doses necessary for maintenance
over a period of many years without serious
sequelae. Our largest controlling dose was 4 grams
per day; and as the chart indicates this was nec-
essary in only two cases. Our suppressive dose
was almost uniform in all cases. The reactions re-
corded in the table were all of a minor nature and
in no instance did they require cessation of treat-
ment.
Table III represents in graphic form an analysis
of the world literature. We found that we could
best translate the various reports and alleged
types by placing them in four main groups. Hav-
ing so arranged them, we may now well ask: What
is dermatitis herpetiformis? What shall be the
criteria for diagnosis? Are the cases of bullous
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TABLE II
Cases treated with sulfapyridine
Pa-
tient ge
Duration
of disease
Sex at onset
of treat-
ment
TABLE I
Dermatitis her petiformis (summary of article) *
Prodromata—systemic complaints or pruritus.
Occurs in both sexes and in women independent
of pregnancy.
Severe itching and burning.
Principal varieties—erythematous, papular, ve-
sicular, bullous, pustular and mixed.
The typical and commonest type—herpetic na-
ture (small groups or clusters of vesicles).
Multiformity and irregularity in order of develop-
ment of lesions.
Excoriations and pigmentation—diffuse or local-
ized in old cases.
All regions liable to invasion including both flexor
and extensor surfaces, the face and the scalp,
elbows and knees, palms and soles.
Disposition to repeated successive outbreaks.
Chronic variable course often lasting years.
Exceedingly rebellious to treatment.
Herpes gestationis is same disease.
Dermatitis herpetiformis is sufficiently compre-
hensive and appropriate to include all varieties
of the process.
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11
3
13
4
1
3
1
10
14
5
1
4
8
2
7
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I
3
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14
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3
5
2
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paula
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Leuco-
penis
Nausea
Malaise
Stoma-
titis
Leuco-
penia
Nausea
Leuco-
penia
Nausea
* Louis A. Duhring, J.A.M.A., Vol. III, Aug.
30, 1884, pp. 225.
dermatitis herpetiformis in children and of the
aged, and herpes gestationis variants or separate
entities? Can dermatitis herpetiformis be a symp-
tom complex of various underlying diseases?
The authors can accept the idea of some bullae
formation in dermatitis herpetiformis, but find it
difficult to include those instances of predomi-
nantly bullous eruption of a generalized and ex-
plosive nature and associated with systemic re-
action. The view of dermatitis herpetiformis as
maintained by the French school under the con-
cept of "dermatite polymorphe douloureuse"
(Brocq)'0 and characterized by a predominantly
bullous eruption with oral lesions and lack of
grouping is to our way of thinking an overexten-
sion of the term.
It is true that typical dermatitis herpetiformis
occurs but rarely in children.1' We cannot accept
those cases diagnosed as bullous dermatitis her-
petiformis in children; we believe the diagnosis
has been overextended. The striking clinical fea-
tures of these cases are: lack of symmetry, pre-
dominancy of bullae, frequent mucous membrane
involvement, minimal or absence of grouping,
minimal or absence of pruritus, absence of scar-
ring, decreased tendency to pigmentation, and
the inconstant or complete lack of response to
treatment with sulfapyridine.
Sneddon and Church12 in reporting a group of
bullous eruptions in the aged separated them from
dermatitis herpetiformis and concluded that der-
matitis herpetiformis as such is uncommon in the
aged. They particularly emphasized the lack of
response to sulfapyridine and the sulfones.
It is not our purpose to enter into a discussion
of the controversial term pemphigoid as related
to certain bullous eruptions. We are interested in
the term merely as it concerns our own thesis and
concept of dermatitis herpetiformis. Lever'3 has
outlined the difficulty of differentiating between
pemphigoid, erythema multiforme and dermatitis
herpetiformis. Although they may resemble each
other clinically and pathologically, he does, how-
ever delineate definite morphological and clinical
features which tend to separate them. Moreover,
with regard to the pathology he calls attention to
the fact that the subepidermal bulla is not specffic
for these two entities. He also stated that his
cases of bullous pemphigoid did not respond to
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Dermatitis herpetiformis summarized from the literature up to 1956
Group 1 Group 2 Group 3 Group 4
Predominantly disease of male (Knowles 1907) (Sobye 1945) 50—70 years of age Associated with various dis-
adults (Gardiner 1909) (Evans 1949) Acute onset eases & conditions (symp-
Good health (Goodman 1941) (Berlin 1952) Systemic reactions tom-complex; Weiss 1942)
Painful or itching Disease of children Painful or markedly pruritic Carcinoma of labium; Bogrow
Papulo-vesioular, symmetrical Acute onset following acute in- Bullous lesions appearing on 1909
& grouping factious disease erythematous macules or Choriocarcinoma; Eliot 1938
Pigmentation & scarring Systemic reactions plaques Bronchiectasis; Weidman 1938
No mucous membrane lesions Itching almost absent Generalized, symmetrical, less Carcinoma of pancreas; Traub
Chronicity with remissions Bullous eruption—no multi- grouping 1940
Response to sulfapyridine & formity Mucous membranes may be in- Pneumoccocal pneumonia;
sulfouns Generalized symmetrical,
with less grouping, little pig-
mentation & no scarring
Mucous membrane lesions
may be present
May be secondary infection
Attacks recurrent
Responds to sulfapyridine &
sulfones—oecasionaily to an-
tibiotics
valved
Pigmentation but no scarring
Recurrent attacks with remis-
sions
Responds to sulfapyridine, u1-
fones & occasionally to anti-
biotics
Are these the same disease?
Erythema multiforme type of
dermatitis herpetiformis
Erythema multiforme pem-
phigoides
Bullous pemphigoid (Lever)
Senile dermatitis herpetifor-
mis
Benign chronic pemphigus
Pemphigoid (Rook)
Para-pemphigus
Cailaway & Sternbcrg 1941
Scirrhous carcinoma of stoin-
ach; Ushland 1942
Lymphosarcoma; Bernstein
1942
Papillary carcinoma of right
ovary; Tobias 1951
Glandular tuberculosis; Oar-
dinghi & Nannelli 1951
Vaccination, pregnancy, foetal
death, psychosomatic epi-
sodes, hallogen allergy, etc.
Questions to be answered:
What is Dermatitis Herpetiformis?
What shall be the criteria for diagnosis?
Are Bullous Dermatitis lierpetiformis of children and of the aged and Herpes Gcstationis variants of Dermatitis Herpetiformis
or separate entities?
Can Dermatitis Herpetiformis be a symptom complex of various underlying diseases and conditions?
sulfapyridine, whereas his cases of dermatitis
herpetiformis did respond.
Rook and Waddington'4 state that the natural
history of the two conditions constitute sufficient
ground to keep them as distinct groups. Prakken
and Woerdernan'5 also separate these entities.
We have mentioned the early literature and
reports of herpes gestationis. The fact is that
herpes gestationis is a rather uncommon mani-
festation of pregnancy.16 One cannot readily
accept Duhring's statement that herpes gesta-
tiones resembles dermatitis herpetiformis in every
respect except the cause. 'While it is true that an
occasional case may develop what seemingly is a
true dermatitis herpetiformis, we again call atten-
tion to the lack of symmetry, decreased tendency
to pigmentation, marked bullae formation, lack
of response to sulfapyridine and the good response
to steroid'7 therapy. More particularly do we call
attention to the self-limitation of this condition
as opposed to true dermatitis herpetiformis.
In Table III we have made reference to the
reported instances of the appearance of a derma-
titis herpetiformis-like picture in association with
various systemic diseases.'8 Again we believe that
a close analysis of these cases would indicate on
the basis of our criteria an over-extension of the
term dermatitis herpetiformis as applied to them.
Sneddon and Wilkinson'9 described a group of
cases under the title of subcorneal pustular der-
matosis. These were characterized by chronic
vesiculo-pustular eruptions affecting for the most
part middle aged women. Although clinically
there was some suggestion that it resembled der-
matitis herpetiformis and responded to diamino-
diphenyl sulfone (dapsone), they felt that it was
a separate entity. This indicates another step in
the more accurate definition of a clinical entity.
In conclusion, we believe that the experience
with our group of cases and a critical review of
the literature would indicate that there exists a
group of cases within the large clinical concept of
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dermatitis herpetiformis which behave alike as
to history, symptomatology, physical findings and
therapeutic response. We believe that the diag-
nosis of dermatitis herpetiformis should be limited
to this group and that the other types belong to
the broader category of bullous erythema multi-
forme.
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DISCUSSION
Dn. HERMAN BEERMAN (Philadelphia, Penna.):
Dr. Tolman, a modest man, questioned why he
was here. I think I better tell you. It was my
committee who selected him and I believe it was
a wise choice in connection with the presentation
of the Presidential Address on Morphology (J.
Invest. Dermat., 31: 203, 1958).
I think our famous great founder of dermatol-
ogy at the University of Pennsylvania, Dr.
Duhring, had in mind that dermatitis herpeti-
formis was a protean lesion disease. It has many
other than bullous lesions and furthermore the
name means group.
Dn. CLARENCE S. L1YINGOOD (Detroit, Michi-
gan): I agree with Dr. Tolman that it is a mis..
take to group all of these questionable cases under
one diagnosis.
Also, I agree with Dr. Lever who, in his classic
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monographic article on pemphigus discusses the
so-called pemphogoid eruption and states that it
is preferable to consider this an entity separate
and distant from bullous dermatitis herpetiformis.
During the last 18 months, we have had an oppor-
tunity to follow closely, three patients who have
pemphigoid eruptions. Sulfapyridine and proma-
cetin were not effective in any of these patients,
although at times their lesions were not unlike
those seen in typical cases of dermatitis herpeti-
formis. The only therapeutic approach which
was effective in these patients was systemic
steroid therapy. In each case it was possible to
reduce the dose gradually over a period of several
months and eventually discontinue treatment
without recurrence of the bullous lesions.
DR. HAROLD M. JomcsoN (Honolulu, Hawaii):
Those of us trained at the University of Pennsyl-
vania under the direct discipline of Dr. John H.
Stokes believe that dermatitis herpetiformis is
definitely an entity. I think all of us have a ten-
dency to group them together and yet I think we
miss the boat on that basis.
Da. GUSTAV ASBOE-HANSEN (Copenhagen,
Denmark): I have seen two cases within a fairly
short time of pemphigus vulgaris treated with
steroids over a fairly long time. Primarily, they
responded to the steroids but the disease flared
up when we decreased the dose. Gradually these
two patients presented the clinical picture of
dermatitis herpetiformis after recurrence, and
the responsiveness to steroids was decreasing
with the time.
Dn. MAURICE M. ToritAN (in closing): I might
say that this is preliminary to an attempt to
study and define the natural course and mech-
anism behind this entity.
As to the rest of the discussion, all I can say
is let the paper speak for itself.
